226 related articles for article (PubMed ID: 14639602)
1. p53 polymorphic variants at codon 72 exert different effects on cell cycle progression.
Pim D; Banks L
Int J Cancer; 2004 Jan; 108(2):196-9. PubMed ID: 14639602
[TBL] [Abstract][Full Text] [Related]
2. The codon 72 polymorphic variants of p53 have markedly different apoptotic potential.
Dumont P; Leu JI; Della Pietra AC; George DL; Murphy M
Nat Genet; 2003 Mar; 33(3):357-65. PubMed ID: 12567188
[TBL] [Abstract][Full Text] [Related]
3. TP53 codon 72 polymorphisms in favorable histology Wilms tumors.
Cost NG; Mitui M; Khokhar S; Wickiser JE; Baker LA; Rakheja D
Pediatr Blood Cancer; 2012 Aug; 59(2):326-8. PubMed ID: 22052810
[TBL] [Abstract][Full Text] [Related]
4. Differential levels of transcription of p53-regulated genes by the arginine/proline polymorphism: p53 with arginine at codon 72 favors apoptosis.
Jeong BS; Hu W; Belyi V; Rabadan R; Levine AJ
FASEB J; 2010 May; 24(5):1347-53. PubMed ID: 20019240
[TBL] [Abstract][Full Text] [Related]
5. p53 mutation arising in Arg72 allele in the tumorigenesis and development of carcinoma of the urinary tract.
Furihata M; Takeuchi T; Matsumoto M; Kurabayashi A; Ohtsuki Y; Terao N; Kuwahara M; Shuin T
Clin Cancer Res; 2002 May; 8(5):1192-5. PubMed ID: 12006537
[TBL] [Abstract][Full Text] [Related]
6. p53 codon 72 polymorphism as a risk factor in the development of breast cancer.
Papadakis EN; Dokianakis DN; Spandidos DA
Mol Cell Biol Res Commun; 2000 Jun; 3(6):389-92. PubMed ID: 11032762
[TBL] [Abstract][Full Text] [Related]
7. An upstream estrogen response element linked to exogenous p53 tumor suppressor gene expression differentiates effects of the codon 72 polymorphism.
Honda K; Kajitani K; Nobeyama H; Kira Y; Yabunaka Y; Egami M; Zhi X; Fukuda T; Yoshida H; Matsumoto Y; Ichimura T; Yaui T; Sumi T; Ishiko O
Asian Pac J Cancer Prev; 2011; 12(4):865-8. PubMed ID: 21790217
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of the proline form of p53 codon 72 polymorphism in nasopharyngeal carcinoma.
Tsai MH; Lin CD; Hsieh YY; Chang FC; Tsai FJ; Chen WC; Tsai CH
Laryngoscope; 2002 Jan; 112(1):116-9. PubMed ID: 11802048
[TBL] [Abstract][Full Text] [Related]
9. Lack of evidence that proline homozygosity at codon 72 of p53 and rare arginine allele at codon 31 of p21, jointly mediate cervical cancer susceptibility among Indian women.
Bhattacharya P; Sengupta S
Gynecol Oncol; 2005 Oct; 99(1):176-82. PubMed ID: 16054204
[TBL] [Abstract][Full Text] [Related]
10. Association of Trp53 polymorphic variants at codon 72 with nonsyndromic mental retardation.
Saccucci P; Galasso C; Rizzo R; Gagliano A; Refice F; Lalli C; Verrotti A; Gloria-Bottini F; Curatolo P
Neurosci Res; 2007 Sep; 59(1):47-50. PubMed ID: 17597242
[TBL] [Abstract][Full Text] [Related]
11. The p53 codon 72 proline allele is associated with p53 gene mutations in non-small cell lung cancer.
Hu Y; McDermott MP; Ahrendt SA
Clin Cancer Res; 2005 Apr; 11(7):2502-9. PubMed ID: 15814626
[TBL] [Abstract][Full Text] [Related]
12. Cycloheximide suppresses radiation-induced apoptosis in MOLT-4 cells with Arg72 variant of p53 through translational inhibition of p53 accumulation.
Ito A; Morita A; Ohya S; Yamamoto S; Enomoto A; Ikekita M
J Radiat Res; 2011; 52(3):342-50. PubMed ID: 21467739
[TBL] [Abstract][Full Text] [Related]
13. p53-dependent activation of microRNA-34a in response to etoposide-induced DNA damage in osteosarcoma cell lines not impaired by dominant negative p53 expression.
Novello C; Pazzaglia L; Conti A; Quattrini I; Pollino S; Perego P; Picci P; Benassi MS
PLoS One; 2014; 9(12):e114757. PubMed ID: 25490093
[TBL] [Abstract][Full Text] [Related]
14. Frequency of TP53 mutations in relation to Arg72Pro genotypes in non small cell lung cancer.
Lind H; Ekstrøm PO; Ryberg D; Skaug V; Andreassen T; Stangeland L; Haugen A; Zienolddiny S
Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):2077-81. PubMed ID: 17932356
[TBL] [Abstract][Full Text] [Related]
15. p53 codon 72 polymorphism and risk of cervical carcinoma in Korean women.
Baek WK; Cho JW; Suh SI; Suh MH; Shin DH; Cho CH; Lee TS; Cha SD
J Korean Med Sci; 2000 Feb; 15(1):65-7. PubMed ID: 10719811
[TBL] [Abstract][Full Text] [Related]
16. The influence of the p53 codon 72 polymorphism on ovarian carcinogenesis and prognosis.
Buller RE; Sood A; Fullenkamp C; Sorosky J; Powills K; Anderson B
Cancer Gene Ther; 1997; 4(4):239-45. PubMed ID: 9253509
[TBL] [Abstract][Full Text] [Related]
17. The codon 72 polymorphism-specific effects of human p53 are absent in mouse cells: implications on generation of mouse models.
Phang BH; Sabapathy K
Oncogene; 2007 May; 26(21):2964-74. PubMed ID: 17130838
[TBL] [Abstract][Full Text] [Related]
18. Induction of apoptosis by the p53-273L (Arg --> Leu) mutant in HSC3 cells without transactivation of p21Waf1/Cip1/Sdi1 and bax.
Kaneuchi M; Yamashita T; Shindoh M; Segawa K; Takahashi S; Furuta I; Fujimoto S; Fujinaga K
Mol Carcinog; 1999 Sep; 26(1):44-52. PubMed ID: 10487521
[TBL] [Abstract][Full Text] [Related]
19. Proline homozygosity in codon 72 of TP53 is a factor of susceptibility to nasopharyngeal carcinoma in Tunisia.
Hadhri-Guiga B; Toumi N; Khabir A; Sellami-Boudawara T; Ghorbel A; Daoud J; Frikha M; Gargouri A; Mokdad-Gargouri R
Cancer Genet Cytogenet; 2007 Oct; 178(2):89-93. PubMed ID: 17954263
[TBL] [Abstract][Full Text] [Related]
20. P53 (Pro72Arg) polymorphism associated with the risk of oral squamous cell carcinoma in gutka, niswar and manpuri addicted patients of Pakistan.
Saleem S; Azhar A; Hameed A; Khan MA; Abbasi ZA; Qureshi NR; Ajmal M
Oral Oncol; 2013 Aug; 49(8):818-23. PubMed ID: 23683469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
